Sekine, Keisuke http://orcid.org/0000-0001-5133-0876
Ogawa, Shimpei
Tsuzuki, Syusaku
Kobayashi, Tatsuya
Ikeda, Kazuki http://orcid.org/0000-0003-0407-0420
Nakanishi, Noriko
Takeuchi, Kenta
Kanai, Eriko
Otake, Yugo
Okamoto, Satoshi
Kobayashi, Tsuyoshi
Takebe, Takanori
Taniguchi, Hideki
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (16K15597, 18K19589)
Keisuke Sekine
Shimpei Ogawa is employed by Ajinomoto Co., Inc.
Shimpei Ogawa
Tsuyoshi Kobayshi is employed by Ajinomoto Co., Inc.
Tsuyoshi Kobayshi
Japan Agency for Medical Research and Development (18bm0304002h0006)
Hideki Taniguchi
Article History
Received: 23 January 2020
Accepted: 23 September 2020
First Online: 21 October 2020
Competing interests
: ShO and TsK are employed by Ajinomoto Co., Inc. SaO, TT and HT have served on Healios scientific advisory boards. TT and HT have also granted a license to Healios through Yokohama City University for their inventions related to the subject of this article. TT and HT are currently conducting research under a collaborative research agreement with Healios, and their research is also related to the subject of this article. KS and HT conducted research under a collaborative research agreement with Ajinomoto, and their research is related to the subject of this article. ST, TaK, KI, NN, KT, EK, and YO declare no competing interests.